CSU secures $3.1 million from NIH to advance SolaVAX coronavirus vaccine research
Contact for reporters: Mary Guiden (206) 854-3786 mary.guiden@colostate.edu A team of scientists at Colorado State University was awarded a base contract worth $3.1 million from the National Institutes of Health to continue development of a coronavirus vaccine candidate known as …